Experienced in Meier-Gorlin Syndrome

Dr. Scott Plotkin

Neurology
Office
55 Fruit St # 9, 
Boston, MA 
Offers Telehealth
Experienced in Meier-Gorlin Syndrome
Office
55 Fruit St # 9, 
Boston, MA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Scott Plotkin is a Neurologist in Boston, Massachusetts. Dr. Plotkin is rated as an Experienced provider by MediFind in the treatment of Meier-Gorlin Syndrome. His top areas of expertise are Schwannomatosis, Neurofibromatosis Type 2 (NF2), Neurofibromatosis, and Acoustic Neuroma.

His clinical research consists of co-authoring 188 peer reviewed articles and participating in 12 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Neurology
Licenses
Psychiatry & Neurology in MA
Hospital Affiliations
Massachusetts General Hospital
Massachusetts Eye And Ear Infirmary -
Brigham And Women's Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
BMC HealthNet
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 5 Less Insurance Carriers -

Locations

Office
55 Fruit St # 9, Boston, MA 02114

Additional Areas of Focus

Dr. Plotkin has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

12 Clinical Trials

Prospective, Randomized, Placebo-Controlled Phase II Trial of Aspirin for Vestibular Schwannomas
Prospective, Randomized, Placebo-Controlled Phase II Trial of Aspirin for Vestibular Schwannomas
Enrollment Status: Active_not_recruiting
Publish Date: December 18, 2025
Intervention Type: Drug
Study Drug: Aspirin
Study Phase: Phase 2
A Phase II Study of Binimetinib in Children and Adults With NF1 Associated Plexiform Neurofibromas (PNOC010)
A Phase II Study of Binimetinib in Children and Adults With NF1 Associated Plexiform Neurofibromas (PNOC010)
Enrollment Status: Completed
Publish Date: May 02, 2025
Intervention Type: Drug
Study Drug: Binimetinib
Study Phase: Phase 2
A Phase 1/2 Study of Selinexor in Combination With Standard of Care (SoC) Therapy for Newly Diagnosed or Recurrent Glioblastoma
A Phase 1/2 Study of Selinexor in Combination With Standard of Care (SoC) Therapy for Newly Diagnosed or Recurrent Glioblastoma
Enrollment Status: Terminated
Publish Date: December 16, 2024
Intervention Type: Drug, Device, Radiation
Study Drugs: Selinexor, Temozolomide (TMZ), Lomustine (CCNU), Bevacizumab, Carmustine
Study Phase: Phase 1/Phase 2
A Phase 2 Randomized, Double-blind, Placebo-Controlled Study of the Analgesic Efficacy and Safety of the Subcutaneous Administration of the Anti-NGF Antibody Tanezumab in Subjects With Moderate to Severe Pain Due to Schwannomatosis
A Phase 2 Randomized, Double-blind, Placebo-Controlled Study of the Analgesic Efficacy and Safety of the Subcutaneous Administration of the Anti-NGF Antibody Tanezumab in Subjects With Moderate to Severe Pain Due to Schwannomatosis
Enrollment Status: Active_not_recruiting
Publish Date: March 13, 2024
Intervention Type: Drug
Study Drug: Tanezumab
Study Phase: Phase 2
A Phase II Study of Cabozantinib (XL184) for Plexiform Neurofibromas in Subjects With Neurofibromatosis Type 1 in Children and Adults
A Phase II Study of Cabozantinib (XL184) for Plexiform Neurofibromas in Subjects With Neurofibromatosis Type 1 in Children and Adults
Enrollment Status: Completed
Publish Date: May 24, 2023
Intervention Type: Drug
Study Drug: Cabozantinib
Study Phase: Phase 2
A Phase 2 Study Evaluating the Efficacy and Safety of Selinexor (KPT-330) in Patients With Recurrent Gliomas
A Phase 2 Study Evaluating the Efficacy and Safety of Selinexor (KPT-330) in Patients With Recurrent Gliomas
Enrollment Status: Terminated
Publish Date: January 26, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Single Arm Phase II Study Of The Dual mTORC1/mTORC2 Inhibitor Vistusertib (AZD2014) Provided On An Intermittent Schedule For Sporadic Patients With Grade II-III Meningiomas That Recur Or Progress After Surgery And Radiation
A Single Arm Phase II Study Of The Dual mTORC1/mTORC2 Inhibitor Vistusertib (AZD2014) Provided On An Intermittent Schedule For Sporadic Patients With Grade II-III Meningiomas That Recur Or Progress After Surgery And Radiation
Enrollment Status: Unknown
Publish Date: October 18, 2022
Intervention Type: Drug
Study Drug: AZD2014
Study Phase: Phase 2
A Single Arm Phase 2 Study of the Dual mTORC1/mTORC2 Inhibitor AZD2014 Provided on an Intermittent Schedule for Neurofibromatosis 2 Patients With Progressive or Symptomatic Meningiomas
A Single Arm Phase 2 Study of the Dual mTORC1/mTORC2 Inhibitor AZD2014 Provided on an Intermittent Schedule for Neurofibromatosis 2 Patients With Progressive or Symptomatic Meningiomas
Enrollment Status: Completed
Publish Date: June 13, 2022
Intervention Type: Drug
Study Phase: Phase 2
A Study of INFUSE Bone Graft (Recombinant Human Bone Morphogenetic Protein-2/Absorbable Collagen Sponge) in the Treatment of Tibial Pseudarthrosis in Neurofibromatosis 1 (NF1)
A Study of INFUSE Bone Graft (Recombinant Human Bone Morphogenetic Protein-2/Absorbable Collagen Sponge) in the Treatment of Tibial Pseudarthrosis in Neurofibromatosis 1 (NF1)
Enrollment Status: Terminated
Publish Date: October 27, 2021
Intervention Type: Procedure, Device
Study Phase: Not Applicable
Open-label, Phase 2 Study of Bevacizumab in Children and Young Adults With Neurofibromatosis 2 and Progressive Vestibular Schwannomas That Are Poor Candidates for Standard Treatment With Surgery or Radiation
Open-label, Phase 2 Study of Bevacizumab in Children and Young Adults With Neurofibromatosis 2 and Progressive Vestibular Schwannomas That Are Poor Candidates for Standard Treatment With Surgery or Radiation
Enrollment Status: Completed
Publish Date: February 12, 2021
Intervention Type: Drug
Study Phase: Phase 2
Exploration and Estimation of Intratumoral Concentration and Activity of Lapatinib in Vivo in Vestibular Schwannomas
Exploration and Estimation of Intratumoral Concentration and Activity of Lapatinib in Vivo in Vestibular Schwannomas
Enrollment Status: Completed
Publish Date: January 12, 2021
Intervention Type: Drug
Study Phase: Early Phase 1
Resiliency Training for Adolescent Neurofibromatosis Patients Via Videoconferencing With Skype
Resiliency Training for Adolescent Neurofibromatosis Patients Via Videoconferencing With Skype
Enrollment Status: Completed
Publish Date: August 17, 2018
Intervention Type: Behavioral
Study Phase: Not Applicable
View 11 Less Clinical Trials

188 Total Publications

Medical therapy for vestibular schwannoma.
Medical therapy for vestibular schwannoma.
Journal: Handbook of clinical neurology
Published: October 06, 2025
Similar Doctors
Chun Lim
Advanced in Meier-Gorlin Syndrome
Dr. Chun Lim
Neurology
Advanced in Meier-Gorlin Syndrome
Dr. Chun Lim
Neurology

BIDMC Department Of Neurology

330 Brookline Avenue, Kirstein 253, 
Boston, MA 
 (2.5 miles away)
617-667-4074
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Chun Lim is a Neurologist in Boston, Massachusetts. Dr. Lim is rated as an Advanced provider by MediFind in the treatment of Meier-Gorlin Syndrome. His top areas of expertise are Cerebellar Degeneration, Lewy Body Dementia (LBD), Memory Loss, and Alzheimer's Disease.

Experienced in Meier-Gorlin Syndrome
Dr. Saumya Jamuar
Neurology
Experienced in Meier-Gorlin Syndrome
Dr. Saumya Jamuar
Neurology

Massachusetts General Hospital

55 Fruit St, 
Boston, MA 
 (0.1 miles away)
617-726-5718
Languages Spoken:
English

Saumya Jamuar is a Neurologist in Boston, Massachusetts. Dr. Jamuar is rated as an Advanced provider by MediFind in the treatment of Meier-Gorlin Syndrome. His top areas of expertise are Agyria Pachygyria Polymicrogyria, Cardiofaciocutaneous Syndrome, RASopathies, Cortical Dysplasia, and Gastrostomy.

Experienced in Meier-Gorlin Syndrome
Dr. Chizoba Umeh
Neurology
Experienced in Meier-Gorlin Syndrome
Dr. Chizoba Umeh
Neurology

Lahey Hospital & Medical Center

41 Mall Rd, 
Burlington, MA 
 (10.9 miles away)
781-744-8630
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Chizoba Umeh is a Neurologist in Burlington, Massachusetts. Dr. Umeh is rated as a Distinguished provider by MediFind in the treatment of Meier-Gorlin Syndrome. Her top areas of expertise are Movement Disorders, Parkinson's Disease, Essential Tremor, and Drug Induced Dyskinesia.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Plotkin's expertise for a condition
ConditionClose
View All 9 Elite Conditions
View All 15 Distinguished Conditions
View All 14 Advanced Conditions
View All 51 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile